Profil

dr. Leovinna, SpPK, telah tergabung dengan Kelompok Staf Medik Patologi Klinik RS Kanker Dharmais.

Beberapa karya ilmiah bersama dengan sejawat senior diantaranya:

Noorwati Sutandyo, Evi Firna, Julyanti Agustina, Nugroho Prayogo, Leovinna Widjaja. Clinicopathology Profile and Bone Involvement of Multiple Myeloma Patients in Dharmais National Cancer Hospital, Indonesia. Asian Pac J Cancer Prev 2015;16(15):6261-5.

Yusra Yusra, Leovinna Widjaja, Fiastuti Witjaksono, Ina S. Timan, July Kumalawati, Sri Suryo Adiyanti, Siti Nurbaya, and Suzanna Immanuel. Amino acid profile in patients of chronic kidney disease on hemodialysis in Indonesia. AIP Conference Proceedings 2353, 030014 (2021); https://doi.org/10.1063/5.0052847

Lianda Siregar, Imelda Maria Loho, Agus Sudiro Waspodo, Siti Nadliroh, Rahmanandhika Swadari, Rizka Andalusia, Leovinna Widjaja. Real-World Experience of Telbivudine and Lamivudine as Antiviral Prophylaxis for Chemotherapy-Related Hepatitis B Reactivation. Indonesian J Cancer 2021;15. DOI: 10.33371/ijoc.v15i1.767

1. Sutandyo, A.M. Jayusman, L. Widjaja, F. Dwijayanti, P. Imelda, A.R. Hanafi. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as mortality predictor of advanced stage non-small cell lung cancer (NSCLC) with COVID-19 in Indonesia. Eur Rev Med Pharmacol Sci 2021; 25 (10): 3868-3878

Pendidikan

Tahun 2007     : Dokter, Fakultas Kedokteran Universitas Indonesia, Jakarta

Tahun 2020     : Spesialis Patologi Klinik, Fakultas Kedokteran Universitas Indonesia, Jakarta